Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310940908> ?p ?o ?g. }
- W4310940908 endingPage "110" @default.
- W4310940908 startingPage "96" @default.
- W4310940908 abstract "Abstract Objective Obesity is a growing global concern compounded by limited availability of effective treatment options. The SURMOUNT development program aims to evaluate the efficacy and safety of tirzepatide as an adjunct to lifestyle intervention compared with placebo on chronic weight management in adults with BMI ≥ 27 kg/m 2 with or without type 2 diabetes. Methods The SURMOUNT program includes four global phase 3 trials NCT04184622 (SURMOUNT‐1), NCT04657003 (SURMOUNT‐2), NCT04657016 (SURMOUNT‐3), and NCT04660643 (SURMOUNT‐4). Participants are randomized to once‐weekly subcutaneous tirzepatide versus placebo in a double‐blind manner. The primary end point in all trials is the percentage change in body weight from randomization to end of treatment. Results for the primary end point for SURMOUNT‐1 were published recently and results for the other trials are expected in 2023. Results Across trials, participants have a mean age of 44.9 to 54.2 years, are mostly female (50.7% to 69.7%), and have a mean BMI of 36.1 to 38.9. Conclusions The extensive assessment of once‐weekly tirzepatide in the global SURMOUNT program will detail the clinical effects of this first‐in‐class glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 receptor agonist in chronic weight management." @default.
- W4310940908 created "2022-12-21" @default.
- W4310940908 creator A5010753663 @default.
- W4310940908 creator A5017401077 @default.
- W4310940908 creator A5021408335 @default.
- W4310940908 creator A5046839756 @default.
- W4310940908 creator A5051043505 @default.
- W4310940908 creator A5056385953 @default.
- W4310940908 creator A5062192624 @default.
- W4310940908 creator A5080576431 @default.
- W4310940908 creator A5091091532 @default.
- W4310940908 creator A5091675017 @default.
- W4310940908 date "2022-12-07" @default.
- W4310940908 modified "2023-10-09" @default.
- W4310940908 title "Tirzepatide for the treatment of obesity: Rationale and design of the <scp>SURMOUNT</scp> clinical development program" @default.
- W4310940908 cites W1572485915 @default.
- W4310940908 cites W1957007052 @default.
- W4310940908 cites W1991988767 @default.
- W4310940908 cites W2043731116 @default.
- W4310940908 cites W2063601306 @default.
- W4310940908 cites W2068618758 @default.
- W4310940908 cites W2069685969 @default.
- W4310940908 cites W2084948079 @default.
- W4310940908 cites W2096048424 @default.
- W4310940908 cites W2109366467 @default.
- W4310940908 cites W2139899193 @default.
- W4310940908 cites W2178677810 @default.
- W4310940908 cites W2394582105 @default.
- W4310940908 cites W2609075277 @default.
- W4310940908 cites W2734675357 @default.
- W4310940908 cites W2764142960 @default.
- W4310940908 cites W2784324162 @default.
- W4310940908 cites W2895135221 @default.
- W4310940908 cites W2895666357 @default.
- W4310940908 cites W2896790246 @default.
- W4310940908 cites W2902012675 @default.
- W4310940908 cites W2915948028 @default.
- W4310940908 cites W3004172664 @default.
- W4310940908 cites W3028216699 @default.
- W4310940908 cites W3097840647 @default.
- W4310940908 cites W3131127077 @default.
- W4310940908 cites W3177122952 @default.
- W4310940908 cites W3177393241 @default.
- W4310940908 cites W3183769527 @default.
- W4310940908 cites W3191712049 @default.
- W4310940908 cites W3205201678 @default.
- W4310940908 cites W3210851898 @default.
- W4310940908 cites W3210916260 @default.
- W4310940908 cites W3214171772 @default.
- W4310940908 cites W4207005829 @default.
- W4310940908 cites W4210940103 @default.
- W4310940908 cites W4213419139 @default.
- W4310940908 cites W4248239717 @default.
- W4310940908 cites W4251966062 @default.
- W4310940908 cites W4281934192 @default.
- W4310940908 cites W4310940908 @default.
- W4310940908 cites W807162506 @default.
- W4310940908 doi "https://doi.org/10.1002/oby.23612" @default.
- W4310940908 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36478180" @default.
- W4310940908 hasPublicationYear "2022" @default.
- W4310940908 type Work @default.
- W4310940908 citedByCount "11" @default.
- W4310940908 countsByYear W43109409082022 @default.
- W4310940908 countsByYear W43109409082023 @default.
- W4310940908 crossrefType "journal-article" @default.
- W4310940908 hasAuthorship W4310940908A5010753663 @default.
- W4310940908 hasAuthorship W4310940908A5017401077 @default.
- W4310940908 hasAuthorship W4310940908A5021408335 @default.
- W4310940908 hasAuthorship W4310940908A5046839756 @default.
- W4310940908 hasAuthorship W4310940908A5051043505 @default.
- W4310940908 hasAuthorship W4310940908A5056385953 @default.
- W4310940908 hasAuthorship W4310940908A5062192624 @default.
- W4310940908 hasAuthorship W4310940908A5080576431 @default.
- W4310940908 hasAuthorship W4310940908A5091091532 @default.
- W4310940908 hasAuthorship W4310940908A5091675017 @default.
- W4310940908 hasBestOaLocation W43109409081 @default.
- W4310940908 hasConcept C126322002 @default.
- W4310940908 hasConcept C142724271 @default.
- W4310940908 hasConcept C147583825 @default.
- W4310940908 hasConcept C1862650 @default.
- W4310940908 hasConcept C203092338 @default.
- W4310940908 hasConcept C204243189 @default.
- W4310940908 hasConcept C204787440 @default.
- W4310940908 hasConcept C27081682 @default.
- W4310940908 hasConcept C34320749 @default.
- W4310940908 hasConcept C511355011 @default.
- W4310940908 hasConcept C535046627 @default.
- W4310940908 hasConcept C544821477 @default.
- W4310940908 hasConcept C71924100 @default.
- W4310940908 hasConceptScore W4310940908C126322002 @default.
- W4310940908 hasConceptScore W4310940908C142724271 @default.
- W4310940908 hasConceptScore W4310940908C147583825 @default.
- W4310940908 hasConceptScore W4310940908C1862650 @default.
- W4310940908 hasConceptScore W4310940908C203092338 @default.
- W4310940908 hasConceptScore W4310940908C204243189 @default.
- W4310940908 hasConceptScore W4310940908C204787440 @default.
- W4310940908 hasConceptScore W4310940908C27081682 @default.
- W4310940908 hasConceptScore W4310940908C34320749 @default.